Company
Headquarters: Baton Rouge, LA, United States
Founded: 1982
Employees: 21,000
CEO: Mr. Paul Berthold Kusserow
$5.37 Billion
USD as of April 1, 2022
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
Amedisys, Inc. is an American healthcare company based in Baton Rouge, Louisiana. They are one of the largest home health providers and second largest hospice care provider in the United States. Amedisys provides in-home skilled nursing, physical therapy, occupational therapy and speech language pathology, medical social work, home aides, and hospice and bereavement services, with 11 million patient care visits in 2011. Amedisys employs more than 21,000 individuals at more than 500 locations in 39 states and Washington, D.C. In 2010, annual revenues were approximately $1.6 billion. Amedisys was ranked 999 on the Fortune 1000 in 2011.
Source: Wikipedia, retrieved on March 31, 2022, 8:41 p.m.
Founder(s): William F. Borne
Paul Kusserow (Chairman & CEO) Scott Ginn (CFO & E VP)
Revenue: US$2.071 Billion (Fiscal Year Ended December 31, 2020)
Operating income: US$219.268 Million (Fiscal Year Ended December 31, 2020)
Net income: US$185.184 Million (Fiscal Year Ended December 31, 2020)
Total assets: US$1.567 Billion (Fiscal Year Ended December 31, 2020)
Total equity: US$810.741 Million (Fiscal Year Ended December 31, 2020)
Amedisys, Inc. has the following listings and related stock indices.
Stock: NASDAQ: AMED
Stock: BMV: AMED
Stock: FSX: ADY